Point-of-Care Ultrasound by Nonexpert Operators Demonstrates High Sensitivity and Specificity in Detecting Gallstones: Data from the Samoa Typhoid Fever Control Program
Am J Trop Med Hyg. 2022 Jan 10:tpmd210973. doi: 10.4269/ajtmh.21-0973. Online ahead of print.ABSTRACTApproximately 90% of chronic typhoid carriers with persistent Salmonella enterica serovar Typhi (S. Typhi) gallbladder infection have gallstones. In Samoa, where typhoid fever has been endemic for many decades, risk factors predisposing to the development of gallstones are increasing among adults. The Samoa Typhoid Fever Control Program dispatches a "Typhoid Epidemiologic SWAT Team" to perform a household investigation of every blood culture-confirmed case of acute typhoid fever. Investigations include screening household c...
Source: The American Journal of Tropical Medicine and Hygiene - January 10, 2022 Category: Tropical Medicine Authors: Seth Hoffman Sachin Desai Michael Sikorski Glenn Fatupaito Siaosi Tupua Robert Thomsen Savitra Rambocus Susana Nimarota-Brown Linatupu Punimata Michelle Sialeipata Chandler Tuilagi Jane Han Roy Robins-Browne Take Naseri Myron Levine Source Type: research
Point-of-Care Ultrasound by Nonexpert Operators Demonstrates High Sensitivity and Specificity in Detecting Gallstones: Data from the Samoa Typhoid Fever Control Program
Am J Trop Med Hyg. 2022 Jan 10:tpmd210973. doi: 10.4269/ajtmh.21-0973. Online ahead of print.ABSTRACTApproximately 90% of chronic typhoid carriers with persistent Salmonella enterica serovar Typhi (S. Typhi) gallbladder infection have gallstones. In Samoa, where typhoid fever has been endemic for many decades, risk factors predisposing to the development of gallstones are increasing among adults. The Samoa Typhoid Fever Control Program dispatches a "Typhoid Epidemiologic SWAT Team" to perform a household investigation of every blood culture-confirmed case of acute typhoid fever. Investigations include screening household c...
Source: Am J Trop Med Hyg - January 10, 2022 Category: Infectious Diseases Authors: Seth Hoffman Sachin Desai Michael Sikorski Glenn Fatupaito Siaosi Tupua Robert Thomsen Savitra Rambocus Susana Nimarota-Brown Linatupu Punimata Michelle Sialeipata Chandler Tuilagi Jane Han Roy Robins-Browne Take Naseri Myron Levine Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States. The vaccine is a live-attenuated, chimeric tetravalent dengue vaccine built on a yellow fever 17D backbone. Dengvaxia is safe and effective in reducing dengue-related hospitalizations and severe dengue among persons who have had dengue infection in the past. Previous natural infection is important because Dengvaxia is associated with an increased risk for severe dengue in those who experience their first natural infection (i.e., primary infection) after vaccination. De...
Source: MMWR Recomm Rep - January 3, 2022 Category: Epidemiology Authors: Gabriela Paz-Bailey Laura Adams Joshua M Wong Katherine A Poehling Wilbur H Chen Veronica McNally Robert L Atmar Stephen H Waterman Source Type: research
